Clinical Trials Logo

Vomiting clinical trials

View clinical trials related to Vomiting.

Filter by:

NCT ID: NCT03141645 Completed - Clinical trials for Postoperative Nausea and Vomiting

Comparison of IV Fluid Loading and Ondansetron in Reduction of PONV After LC

Start date: June 20, 2017
Phase: N/A
Study type: Interventional

This study is designed to examine the incidence of postoperative nausea and vomiting during 24 hours after elective laparoscopic cholecystectomy in patients receiving preoperative intravenous fluid loading (group F), ondansetron (group O) and receiving neither fluid nor ondansetron or control group (group C).

NCT ID: NCT03139383 Completed - Clinical trials for Postoperative Nausea and Vomiting

Dextrose Containing Fluid and the Postoperative Nausea and Vomiting in the Gynecologic Laparoscopic Surgery

Start date: September 30, 2014
Phase: N/A
Study type: Interventional

The investigators tested the hypothesis that administration of intravenous dextrose as a maintenance fluid in gynecologic laparoscopic surgery would reduce the incidence and severity of postoperative nausea and vomiting (PONV) compared with normal saline solution in the same dose. A prospective randomized double blinded controlled study was conducted. Eighty six participants were randomized to dextrose solution (n= 42) or normal saline solution (n= 44). The Bellville postoperative nausea and vomiting scores were recorded until 24 hours after surgery.

NCT ID: NCT03137121 Completed - Advanced Cancer Clinical Trials

Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

Start date: July 12, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the use of olanzapine for the treatment of cancer patients with chronic nausea and/or vomiting unrelated to chemotherapy or radiation in a randomized placebo-controlled pilot trial.

NCT ID: NCT03125941 Completed - Breast Cancer Clinical Trials

High vs Low Dose Dexamethasone on Complications in the Immediate Postoperative Phase After Mastectomy

DEX-MAS
Start date: March 27, 2017
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate the effect of a single preoperative high-dose steroid injection on complications in the immediate postoperative phase after breast cancer surgery, with removal of the breast (mastectomy). Primary outcome is the proportion patients who require transfer to the post anaesthesia care unit (PACU) and the proportion that can be transferred directly to the ward. Secondary outcomes are organospecific complications in the postanesthesia phase, pain and nausea the first 5 days, seroma and wound infection the first 14 days and readmissions the first 30 days after surgery. The investigators hypothesize that the frequency of transfer to the PACU and organospecific complications will be lower among patients receiving high dose dexamethasone. The investigators hypothesize, that there will be no difference in wound infections, seroma or readmissions.

NCT ID: NCT03125811 Completed - Nausea Clinical Trials

Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)

VOMIITED
Start date: July 17, 2017
Phase: Early Phase 1
Study type: Interventional

This study will compare two different ways to relieve nausea and vomiting in the Emergency Department. The usual treatment for nausea/vomiting is a drug called Zofran, but new studies have suggested that smelling alcohol pads can also help to relieve nausea and vomiting.

NCT ID: NCT03118986 Recruiting - Nausea Clinical Trials

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Start date: August 10, 2017
Phase: Phase 2
Study type: Interventional

Chemotherapy-induced nausea and vomiting (CINV) are among the most bothersome symptoms during cancer treatment according to children and their parents. Most children receiving highly emetogenic chemotherapy (HEC), including those receiving hematopoietic stem cell transplant (HSCT) conditioning, experience CIV despite receiving antiemetic prophylaxis. Olanzapine improves CINV control in adult cancer patients, has a track record of safe use in children with psychiatric illness, does not interact with chemotherapy and is inexpensive. We hypothesize that the addition of olanzapine to standard antiemetics will improve chemotherapy-induced vomiting (CIV) control in children receiving highly emetogenic chemotherapy

NCT ID: NCT03112278 Active, not recruiting - Tooth Erosion Clinical Trials

Clinical Evaluation of Ultrathin Occlusal Veneers for the Treatment of Severe Dental Erosion

UOVTDE
Start date: November 2015
Phase: N/A
Study type: Interventional

Ultra-thin bonded posterior occlusal veneers represent a conservative alternative to traditional onlays and complete coverage crowns for the treatment of severe erosive lesions. Therefore, the purpose of this study is to determine whether ceramic and composite resin ultrathin occlusal veneers (0.6 - 1.0 mm thick) are effective in the rehabilitation of patients affected by moderate and severe dental erosion.

NCT ID: NCT03104023 Recruiting - Clinical trials for Vomiting, Postoperative

Staple Line Inversion vs Buttressing on Postoperative Vomits After LSG

Start date: January 2017
Phase: Phase 3
Study type: Interventional

Patients undergoing laparoscopic sleeve gastrectomy will be randomized into 2 groups. In one group, a staple line inversion with a running suture of Polypropylene will be performed. In the second group, the gastric section will be performed with a stapler with preloaded buttress material Postoperative nausea and vomits during the first 24 hours will be investigated.

NCT ID: NCT03097588 Completed - Malignant Neoplasm Clinical Trials

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

Start date: April 27, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well netupitant and palonosetron hydrochloride work in preventing chemotherapy induced nausea and vomiting in patients with cancer undergoing BEAM conditioning regimen before stem cell transplant. Chemotherapy, such as carmustine, cytarabine, etoposide, and melphalan (BEAM), makes people feel sick to their stomach and causes vomiting. Netupitant and palonosetron hydrochloride may reduce the nausea and vomiting caused by the BEAM treatment.

NCT ID: NCT03088696 Recruiting - Nausea Clinical Trials

Evaluation of PC 6 "Neiguan" With Conventional Acupuncture to Prevent PONV After Laparoscopic Cholecystectomy.

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Assessment of the effectiveness of PC 6 "Neiguan" with conventional acupuncture for preventing PONV (PostOperative Nausea and Vomiting) after laparoscopic surgery.